전한울
2023년 3월 8일
- ICU acquired weakness 이후의 예후 /리뷰논문
https://www.nejm.org/doi/full/10.1056/NEJMra2104669
The specialty of critical care has achieved important advances in survival for many patients with the most complex disorders. Along with these advances, however, there has been an increasing awareness of the complicated and persistent morbidity that follows critical illness. Episodes of critical illness result in multidimensional acquired or exacerbated conditions that may persist for years after the critical illness and may not be wholly reversible. Health inequities may worsen these outcomes. The coronavirus disease 2019 (Covid-19) pandemic, which has resulted in the largest cohort of critical illness survivors and families in history, heightened awareness of the ubiquity of multidimensional disability after critical illness. A continuum of care for patients and families after critical illness, extending from the intensive care unit (ICU) to community or primary care, must become the standard of care and be developed concurrently with a prioritization of basic science inquiry to elucidate the multiple mechanisms of morbidity. Transparent and public reporting of long-term ICU outcomes is fundamental for obtaining informed consent to initiate and continue ICU treatment, aligning care with patient and family values, and ensuring accountability for the high human and financial costs of these outcomes.
